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1. Introduction 
The acetylcholine (ACh) receptor purified from 
the electric organ of Torpedo (sp) is an oligomer com- 
posed of 4 different subunits having app. Mr-values on 
SDS-polyacrylamide gels of 40 000 (a), 50 000 @), 
60 000 (^I), and 66 000 (8) and a stoichiometry of 
o&S [l-3]. The cx subunit is labeled by affinity 
reagents (TDF [4,5]; MBTA [6,7]; MPTA [8]; BrACh 
[9,10]; DAPA [ 111) known to bind to, or in the close 
vicinity of, the ACh binding site. However, the 6 chain 
reacts covalently with 5A[3H]T [12-141, a photo- 
affinity derivative of the non-competitive blocker tri- 
methisoquin [ 151, and with other reversible noncom- 
petitive blockers (e.g., phencyclidine, histrionicotoxin) 
by simple UV irradiation [161. Other non-competitive 
blockers label subunits in addition to the 6 chain. 
Following UV irradiation, chlorpromazine labels all 
of the subunits [161. Thus, the ACh binding site is 
carried, mainly, by the (Y chain and the site for non- 
competitive blockers, mainly, by the 6 chain, but 
other subunits may also contribute to one or both of 
these sites[ 171. 
differ from the classical curare-like agents by the fact 
that they are polypeptides in nature and of high Mr 
(7000-8000). Because of their size, they may be use- 
ful in exploring the vicinity of the ACh binding site. 
Studies with photolabile derivatives of -bungarotoxin 
{20] or with added crosslinkingagents and radioactive 
o-bungarotoxin [21,22] gave crosslinking products 
of 70?-8000 M, (on SDS-polyacrylamide gels) 
greater than some of the ACh receptor subunits. The 
major crosslinked products were the (Y and 6 chains, 
but the fl and y chains also could be labeled slightly 
under certain conditions [22]. The conclusions were 
that the binding site for snake o-toxins resides on the 
(Y chain; whereas, the other chains, in particular the 
6 subunit, were within crosslinking distance of the 
bound toxin’ or that ‘some if not all of the crosslinking 
was due to diffusion and collision’ [22]. 
The a-toxins from snake venoms behave as com- 
petitive antagonists of AC% for its site [18,19] but 
We have found, using the same method as that used 
with some non-competitive blockers [ 161, that ~1.l~~I- 
bungarotoxin (Bgt) can be crosslinked covalently to 
ACh receptor subunits by simple W irradiation. This 
allows the analysis of toxin-receptor crosslinked pro- 
ducts without the complication of an intervening 
‘crosslinking arm’. 
Abbreviations: ACh, acetylcholine; orBgt, abungarotoxin; 
BrACh, bromoacetylcholine; DAPA, bis(3-azidopyridinium)- 
l,lO-decane perchlorate; EDTA, ethylenediaminetetraacetic 
acid; EGTA, ethylene glycol bis@minoethyl ether)-N,N- 
tetraacetic acid; MBTA, 4-(N-maleimlno)benzyltrimethyl- 
ammonium; MPTA, 4-(N-maleimido)phenyltrimethylammo- 
nium; PMSF, phenylmethanesulfonyl fluoride; SDS, sodium 
dodecyl sulfate; TDF, p-trimethylammonium benzene diazo- 
nium fluoroborate 
2. Methods 
2.1. Preparation of membranes 
* To whom correspondence should be addressed 
ACh receptor-rich membranes were purified from 
freshly dissected Torpedo marrnorata membranes as 
in [ 13,231 using a buffer designed to inhibit endoge- 
nous proteolytic activity (PI buffer: 50 mM Tris-HCl, 
pH 7.5 (20°C), 3 mM EDTA, 1 mM EGTA, 0.1 mM 
PMSF, 5 units aprotinin/ml and 5 l.(g pepstatin/ml). 
Membranes were stored in liquid nitrogen at 20 to 
25 MM in o-Bgt sites until use. 
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2.2. Ultraviolet light-induced crosslinking 3. Results and discussion 
Samples of ACh receptor ich membranes were 
diluted to 10 PM in cw-Bgt sites and incubated with 
varying [a- 1251-Bgt] in PI buffer. After 1 h incuba- 
tion, the mixture was centrifuged for 2 min at top 
speed in a Beckman airfuge. The pellet was washed 
3 times with 170 /J PI buffer by centrifugation and 
resuspension asabove. The pellet was resuspended to
the original volume, and 20 fl aliquots were placed in 
a chamber for irradiation. The chamber was flushed 
with nitrogen for 15 min and the membranes were 
irradiated with a Mineralight short-wave UV lamp 
(Ultra-Violet Products, San Gabriel CA) placed out- 
side the chamber at a distance of 15 cm (254 mn, 
1200 pW/cm2) from the samples. The solutions were 
separated from the light source by a thin sheet of cel- 
lophane that absorbed <5% of the light. The time of 
irradiation varied from l-30 min, with the value for 
each experiment given either in the text or in a tigurr, 
legend. Irradiation times were limited by crosslinkinI 
of receptor subunits, which results in products that 
do not enter the gels, and by the loss of radioactive 
iodine from cu-12’I-Bgt after prolonged irradiation. 
The iodinated species liberated after irradiation did 
not label the receptor peptides as no label corn&rated 
with native receptor subunits. The labeled bands 
migrated on denaturing els with app. Mr 7000-8000 
greater than those of receptor subunits. 
Fig.1 shows that UV irradiation of a-12’I-Bgt 
bound to native ACh receptor-rich membranes from 
Torpedo rnarmorata results in the covalent crosslinking 
of o-r2’I-Bgt o several ACh receptor subunits. After 
SDS-polyacrylamide gel electrophoresis and /I-mer- 
captoethanol (section 2), 3 sharp radioactive bands 
were detected by autoradiography. Their app. Mr was 
48 000,66 000 and 74 000 respectively, which coin- 
cided with the app. Mr of the cr,y and 6 chains increased 
by 7000-8000; i.e., the Mr of ar-Bgt. 
The observed labeling and change in migration of 
the polypeptide chains resisted heating at 100°C for 
5 min and treatment with 5% /I-mercaptoethanol which 
both destroy all o-Bgt binding activity in non-irradiated 
samples. Thus, the labeling did not correspond to a 
low affinity reversible association between cr-Bgt and 
receptor polypeptides [24,25] but to the covalent 
attachment of the o-toxin. 
In general, a% of bound ar-‘2SI-Bgt was recovered 
as a crosslinked product after SDS gel electrophoresis. 
Under these conditions, as shown in fig.lb and 2, the 
Following irradiation, the samples were diluted 
with 20 4 SDS sample buffer (5% SDS, 4% /3-mercap- 
toethanol, 13% glycerol, 0.002% bromphenol blue, 
0.2 M Tris-HCl, pH 6.8 at 2O”C), and 35 /11 were 
layered directly onto SDS-polyacrylamide gels. 95 
2.3. Polyacrylamide gel electrophoresis 
SDS-polyacrylamide gels (10% acrylamide) were 
prepared as in [8] using 1.1 mm thick slabs. Gels were 
stained in 0.5% Coomassie brilliant blue R-250, 
destained, and scanned with a Vernon gel scanner using 
a yellow filter. Gels were then dried and exposed to 
Kodak X-Omat AR film preflashed to an absorbance 
of 0.2. Alternatively, dried gels were cut into 1 mm 
slices and counted in a Beckman multiwell y-counter. 
2.4. Chemicals 
Purified cu-Bgt was a gift of Drs B. Holton and T. 
Saitoh, and (r-‘25LBgt was purchased from NEN. 
Acrylamide, bisacrylamide, and TEMED were pro- 
ducts of Kodak. Live Torpedo marmorata were pro- 
vided by the Biological Station of Arcachon. 
TX. -- 
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Flg.1. Ultraviolet light-induced crosslinking of or-“‘1-Bgt o 
the membrane-bound ACh receptor from Torpedo murmorufa. 
About 3% of the cY-toxin sites were occupied by o-lZsI-Bgt, 
and the irradiation time at 254 run was 20 min. (a) (1) Coo- 
massie blue stain of a 10% polyacryhunide SDS gel showing 
the membrane preparation crosslinked with ar-“‘I-Bgt; (2) 
autoradiogram of the dried gel showing the positions of the 
labeled crosslinked products. 
(b) (1) Scan of the Coomassie blue-stained gel shown in (a,l); 
(2) quantitation of the o-r2’1-Bgt incorporated into receptor 
peptides by counting 1 mm strips of the dried gel. 
stoichiometry of the labeling of the o&$-y and 6 chains 
was 4:0: 1:2. The same stoichiometry was found up 
to irradiation times of -20 min. After this time cross- 
linking between receptor subunits (or possibly other 
extrinsic proteins) began to alter their electrophoretic 
mobility, thus making impossible an accurate measure- 
ment of the crosslinked products. 
The selectivity of the crosslinking process is illus- 
trated in iig.3. Identical crosslinked products were 
observed with the same stoichiometry both when 
only 5% or when 100% of the available sites were 




Fig.2. Time course of the incorporation of o-‘*sI-Bgt into 
ACh receptor subunits. cr-‘asI-Bgt was bound to the ACh 
receptor at 3% saturation, free toxin was removed, and toxin- 
receptor complexes were irradiated at 254 nm for the times 
indicated. Quantitation was performed as in fig.1, and 1000 
cpm represented -2.5% of the total c~-~~~I-Bgt bound. 
incubation with 20 PM unlabeled o-Bgt (fig3B,D) 
completely abolished the crosslinking of cr-12sI-Bgt. 
MBTA, the afiinity reagent known to label the agonist 
(ACh) binding site on the a! chain, inhibited the bind- 
ing of (Y- 12’I-Bgt and, thus, its covalent crosslinking 
(fig3E). The non-competitive blocker phencyclidine 
[14,26] at a concentration 10.fold higher (10 PM) 
than the Kd for its high affinity site had no effect on 
the crosslinking process even when maintained at 
10 MM throughout he washing and irradiation steps. 
The question of whether the portion of the 6 sub- 
unit labeled by the photoafftity reagent for the site 
for non-competitive blockers [12-141, 5-azido-[3H]- 
trimethisoquin (5 A[ 3H] T, [ 1 S]), overlaps the portion 
of the 6 subunit labeled by ar-12’I-Bgt was investigated 
by irradiating complexes of unlabeled ol-Bgt and ACh 
receptor prelabeled with 5A[3H]T. A faint band labeled 
with 3H was observed atthe 72 000 M, position on an 
SDS gel. This band was not present under the follow- 
ing conditions: (i) in non-irradiated samples; (ii) n
samples irradiated in the absence of unlabeled cr-Bgt; 
(iii) in samples in which excess phencyclidine (a specific 
inhibitor of the labeling of the site for non-competitive 
blockers by 5A[ 3H] T) was included in the initial incu- 
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Fig.3. Autoradiograms of the incorporation of o-rz51-Bgt 
into ACh receptor peptides under the following conditions: 
(A) 3% of the o-toxin sites occupied by cy-rz51-Bgt; (B) pre- 
treatment with unlabeled o-Bgt, same concentration of o-rzaI- 
Bgt as in (A); (C) 100% saturation with o-“‘I-Bgt; (D) pre 
treatment with unlabeled o-B@, same concentration of cP51- 
Bgt as in (C); (E) pretreatment of DTT-reduced receptor 
with MFTA, same concentration of o-“*I-Bgt as in (A). (F) 
inclusion of unlabeled phencyclidine (10 PM) in all solutions, 
same concentration of a-“‘1-Bgt as in (A). The large amount 
of radioactivity at the tracking dye in conditions A, C and F 
reflects o-‘251-Bgt bound to the receptor but not covalently 
crosslinked. In conditions B, D and E, a much lower quantity 
of o-rzSI-Bgt was bound due to the presence of inhibitors and 
that which was not bound was washed out prior to irradiation. 
bation with 5A[ 3H] T. The most plausible xplanation 
for this result is that o-Bgt interacts with a portion of 
the cr chain that is distinct from the site for non-com- 
petitive blockers. In addition, this confirms the assump- 
tion that the 72 OOOM, complex is composed of cu-Bgt 
and the S subunit. 
These results are consistent with those in [20-221 
where cy-Bgt was bound covalently to Torpedo califor- 
nica ACh receptor using crosslinking agents or deriva- 
tives of cr-Bgt with photolabile arylazide sidechains. 
In all cases the major crosslinking occurred with the 
LY and 6 chains and to a lesser extent with the y chain 
(review [27]). The major contribution of this study is 
that no ‘crosslinking arm’ was employed so that the 
labeling of the subunits can be assigned to a direct 
interaction of a-Bgt with these chains. The slight 
labeling of the y chain is consistent with the finding 
that, under conditions in which 5A[ ‘H] T labels the 
ACh site, the y chain is also slightly labeled [141. 
The observed stoichiometry of labeling cannot be 
readily interpreted in terms of site stoichiometry since 
only a fraction of the bound toxin molecules are cova- 
lently attached to the receptor chains. Nevertheless, 
the fact that the ratio of incorporation of cu-1251-Bgt 
into the (Y and S chains (2: 1) is the same as the stoi- 
chiometry of these subunits in the 250 OOOM, oligomer 
of the ACh receptor (light form) suggests he possibil- 
ity that the ‘reactivity’ of o-Bgt bound to the ACh 
receptor is the same for the (Y and 6 chains. However, 
this ‘reactivity’ may be smaller with the y chain. Since 
a maximum of 2 cu-Bgt molecules bind/receptor oli- 
gomer (review [27,28]), a possible interpretation of 
these data is that each a-Bgt site is built from 1 (IL 
chain t 1 of the neighboring subunits. Accordingly, 
1 of the a-Bgt sites would be made up of 1 of the (Y 
chains + the 6 chain and the other by the second (Y 
chain t the y chain. This interpretation is consistent 
with the observation that the 2 ACh a-toxin sites 
exhibit different binding properties ([29], review [28]). 
In conclusion, the UV irradiation method for cross- 
linking appears to reflect accurately the interactions 
of a polypeptide ligand with its receptor and, thus, 
could possibly be extended to the study of other 
receptors for polypeptide hormones and neurotrans- 
mitters. 
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